Status:
UNKNOWN
Management Steroid Induced Glaucoma
Lead Sponsor:
Mansoura University
Conditions:
Steroid-Induced Glaucoma
Eligibility:
All Genders
2-70 years
Phase:
NA
Brief Summary
Purpose: To assess the safety and efficacy of Viscotrabeculotomy Versus trabeculectomy with MMC for the management of medically uncontrolled steroid induced glaucoma. Patients and methods: A retros...
Detailed Description
Introduction: Steroid induced glaucoma(SIG) is a form of open-angle glaucoma associated with various modalities of corticosteroid administration such as oral, intravenous, inhaled, ocular instilled, ...
Eligibility Criteria
Inclusion
- Eyes with steroid induced glaucoma when IOP was persistently elevated despite maximal tolerated IOP-lowering therapy with potential or actual compromise of optic nerve structure (progressive optic nerve cupping) and/or function (deterioration of visual field testing)
- A minimum follow-up of 3 years was required for inclusion in the study
Exclusion
- Oher causes and types of glaucoma
Key Trial Info
Start Date :
November 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04673201
Start Date
November 21 2020
End Date
June 1 2021
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university ophthalmic center
Al Mansurah, Dakahlyia, Egypt, 35516